New scan may forecast prostate cancer relapse

NCT ID NCT03976843

Ongoing Knowledge-focused Sponsor: National Cancer Institute (NCI) Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 6 times

Summary

This study tests whether a special PET scan, done before prostate removal surgery, can predict if prostate cancer will come back. About 175 men with high-risk prostate cancer will get the scan, then have surgery, and be followed for up to 5 years. The goal is to see if this scan is better than standard imaging at forecasting cancer return.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK LOCALIZED PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Brigham and Women s Hospital

Boston, Massachusetts, 02115, United States
Johns Hopkins University

Baltimore, Maryland, 21205, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10021, United States
National Institutes of Health Clinical Center

Bethesda, Maryland, 20892, United States
Thomas Jefferson University

Philadelphia, Pennsylvania, 19107-6541, United States
Tulane University

New Orleans, Louisiana, 70112-2699, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.